Pretherapeutic erythrocyte polyamine spe
โ
Bernard G. Cipolla; Jean Ziade; Jean-Yves Bansard; Jacques-Philippe Moulinoux; F
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 902 KB
## BACKGROUND. Androgen deprivation is currently the standard treatment for patients with metastatic prostate carcinoma. Few reliable prognostic markers are able to select, at diagnosis, patients who will respond favorably and durably to hormone ablation. Circulating polyamines, markers of cell pr